Rare Disease Review

Rare Disease Review is a medical & health policy journal focused on providing detailed discourse on rare diseases and their societal effects that anyone can understand.

ISSN 2369-9868

Categories

All tagged Mepolizumab

Mepolizumab: A Key Agent in the Fight against Eosinophilic Granulomatosis with Polyangiitis

Jan 31

Jan 31 Mepolizumab: A Key Agent in the Fight against Eosinophilic Granulomatosis with Polyangiitis

Science & Disease

#%-&GgWwOoqQLlAaSs680